TGFB1 and neoplasm: They release various soluble mediators—such as TGF-β, IL-10, prostaglandin E2 (PGE2), and indoleamine 2,3-dioxygenase (IDO)—that inhibit immune cell activation and promote regulatory T cell differentiation, thereby suppressing anti-tumor immune responses.